tiprankstipranks
pc:panca

Pan Cancer T BV

Pan Cancer T is advancing next-generation TCR-T cell therapies for hard-to-treat solid tumours. Its approach combines exclusive tumour targets robustly expressed across multiple solid cancers and enhanced T cell durability through proprietary technologies. The company’s R&D pipeline includes programs for triple-negative breast cancer (TNBC) and cancers of the skin, colorectum, stomach, oesophagus, ovary and uterus.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$10M
Total Amount Raised$10M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$10M
Latest Funding Amount$10M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 08, 2025
Investment
$10.00M

Investors

Investor Name
Funding Round

Related News and Analysis